医院内静脉血栓栓塞症防治与管理建议

2018-05-15 中国健康促进基金会 中华医学杂志.2018.98(18):1383-1388.

中华医学会血栓栓塞性疾病防治专家委员会于2012年发表了《医院内静脉血栓栓塞症预防与管理建议》,旨在规范、VTE的临床管理,有效开展医院内VTE预防,减少VTE的发生,降低医疗风险,提高医疗质量。近年来,医院内VTE防治和管理体系建设在国内逐渐受到重视,住院患者VTE防治领域循证医学证据不断出现,临床实践指南不断更新。有鉴于此,中国健康促进基金会血栓与血管专项基金专家委员会再次组织国内相关学科专家

中文标题:

医院内静脉血栓栓塞症防治与管理建议

发布机构:

中国健康促进基金会

发布日期:

2018-05-15

简要介绍:

中华医学会血栓栓塞性疾病防治专家委员会于2012年发表了《医院内静脉血栓栓塞症预防与管理建议》,旨在规范、VTE的临床管理,有效开展医院内VTE预防,减少VTE的发生,降低医疗风险,提高医疗质量。近年来,医院内VTE防治和管理体系建设在国内逐渐受到重视,住院患者VTE防治领域循证医学证据不断出现,临床实践指南不断更新。有鉴于此,中国健康促进基金会血栓与血管专项基金专家委员会再次组织国内相关学科专家对《医院内静脉血栓栓塞症预防与管理建议》进行修汀,更新了部分专家建议并补允了一些临床评估量表,供医务人员和医院管理人员参考使用。 

拓展指南:血栓相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=医院内静脉血栓栓塞症防治与管理建议)] GetToolGuiderByIdResponse(projectId=1, id=361bc1c001592292, title=医院内静脉血栓栓塞症防治与管理建议, enTitle=, guiderFrom=中华医学杂志.2018.98(18):1383-1388., authorId=null, author=, summary=中华医学会血栓栓塞性疾病防治专家委员会于2012年发表了《医院内静脉血栓栓塞症预防与管理建议》,旨在规范、VTE的临床管理,有效开展医院内VTE预防,减少VTE的发生,降低医疗风险,提高医疗质量。近年来,医院内VTE防治和管理体系建设在国内逐渐受到重视,住院患者VTE防治领域循证医学证据不断出现,临床实践指南不断更新。有鉴于此,中国健康促进基金会血栓与血管专项基金专家委员会再次组织国内相关学科专家, cover=, journalId=null, articlesId=null, associationId=1223, associationName=中国健康促进基金会, associationIntro=中国健康促进基金会 , copyright=0, guiderPublishedTime=Tue May 15 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<div>中华医学会血栓栓塞性疾病防治专家委员会于2012年发表了《医院内静脉血栓栓塞症预防与管理建议》,旨在规范、VTE的临床管理,有效开展医院内VTE预防,减少VTE的发生,降低医疗风险,提高医疗质量。近年来,医院内VTE防治和管理体系建设在国内逐渐受到重视,住院患者VTE防治领域循证医学证据不断出现,临床实践指南不断更新。有鉴于此,中国健康促进基金会血栓与血管专项基金专家委员会再次组织国内相关学科专家对《医院内静脉血栓栓塞症预防与管理建议》进行修汀,更新了部分专家建议并补允了一些临床评估量表,供医务人员和医院管理人员参考使用。 </div> <div><br> </div>拓展指南:<strong>与<font color=red>血栓</font>相关指南:</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=54d121c001586efe" title="2018 APAGBI指南:儿童患者围术期静脉血栓栓塞的预防" target=_blank>2018 APAGBI指南:儿童患者围术期静脉血栓栓塞的预防</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=9b0471c0015e7917" title="肺血栓栓塞症诊治与预防指南" target=_blank>肺血栓栓塞症诊治与预防指南</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=fe8451c0015e3580" title="NCCN临床实践指南:癌症相关性静脉血栓栓塞性疾病(2018.V1)" target=_blank>NCCN临床实践指南:癌症相关性静脉血栓栓塞性疾病(2018.V1)</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=14bb61c0015509a1" title="2018 BSH指南:儿童恶性肿瘤患者血栓与止血问题的管理" target=_blank>2018 BSH指南:儿童恶性肿瘤患者血栓与止血问题的管理</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=c37241c0015a919e" title="欧洲卒中组织脑静脉血栓形成诊断和治疗指南" target=_blank>欧洲卒中组织脑静脉血栓形成诊断和治疗指南</a></li> 更多信息请点击:<a href="http://www.medsci.cn/guideline/list.do?q=%E8%A1%80%E6%A0%93" target=_blank>有关血栓更多指南</a></ul>, tagList=[TagDto(tagId=74970, tagName=医院内静脉血栓栓塞症), TagDto(tagId=700, tagName=肺栓塞)], categoryList=[CategoryDto(categoryId=92, categoryName=血管外科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=其他, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=13937, appHits=649, showAppHits=0, pcHits=5953, showPcHits=8669, likes=93, shares=49, comments=6, approvalStatus=1, publishedTime=Wed May 16 22:22:07 CST 2018, publishedTimeString=2018-05-15, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Wed May 16 22:22:07 CST 2018, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 11:40:03 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=医院内静脉血栓栓塞症防治与管理建议)])
医院内静脉血栓栓塞症防治与管理建议
下载请点击:
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1079594, encodeId=787110e959439, content=都是干货妥妥哒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2d65095108, createdName=137*****173<手机用户>, createdTime=Mon Dec 13 16:10:51 CST 2021, time=2021-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918032, encodeId=bb8b91803217, content=最近正在学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0775454068, createdName=ms3000002065624587, createdTime=Tue Jan 19 13:09:01 CST 2021, time=2021-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=880591, encodeId=b5dd88059169, content=单位建设VTE防控体系正好用的到 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200829/fccb28c619cc4fc3b977eaa825914952/fd3510755d274e319c95dbcca5d6a542.jpg, createdBy=c8d63658569, createdName=朱大医生, createdTime=Sat Aug 29 14:05:58 CST 2020, time=2020-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=315864, encodeId=2c0c315864e7, content=好文献学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5a62240667, createdName=张新亮1853311252142e2fm, createdTime=Thu May 17 06:51:48 CST 2018, time=2018-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=315768, encodeId=6a19315e6879, content=谢谢分享学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Wed May 16 22:53:13 CST 2018, time=2018-05-16, status=1, ipAttribution=)]
    2021-12-13 137*****173<手机用户>

    都是干货妥妥哒

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1079594, encodeId=787110e959439, content=都是干货妥妥哒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2d65095108, createdName=137*****173<手机用户>, createdTime=Mon Dec 13 16:10:51 CST 2021, time=2021-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918032, encodeId=bb8b91803217, content=最近正在学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0775454068, createdName=ms3000002065624587, createdTime=Tue Jan 19 13:09:01 CST 2021, time=2021-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=880591, encodeId=b5dd88059169, content=单位建设VTE防控体系正好用的到 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200829/fccb28c619cc4fc3b977eaa825914952/fd3510755d274e319c95dbcca5d6a542.jpg, createdBy=c8d63658569, createdName=朱大医生, createdTime=Sat Aug 29 14:05:58 CST 2020, time=2020-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=315864, encodeId=2c0c315864e7, content=好文献学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5a62240667, createdName=张新亮1853311252142e2fm, createdTime=Thu May 17 06:51:48 CST 2018, time=2018-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=315768, encodeId=6a19315e6879, content=谢谢分享学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Wed May 16 22:53:13 CST 2018, time=2018-05-16, status=1, ipAttribution=)]
    2021-01-19 ms3000002065624587

    最近正在学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1079594, encodeId=787110e959439, content=都是干货妥妥哒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2d65095108, createdName=137*****173<手机用户>, createdTime=Mon Dec 13 16:10:51 CST 2021, time=2021-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918032, encodeId=bb8b91803217, content=最近正在学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0775454068, createdName=ms3000002065624587, createdTime=Tue Jan 19 13:09:01 CST 2021, time=2021-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=880591, encodeId=b5dd88059169, content=单位建设VTE防控体系正好用的到 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200829/fccb28c619cc4fc3b977eaa825914952/fd3510755d274e319c95dbcca5d6a542.jpg, createdBy=c8d63658569, createdName=朱大医生, createdTime=Sat Aug 29 14:05:58 CST 2020, time=2020-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=315864, encodeId=2c0c315864e7, content=好文献学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5a62240667, createdName=张新亮1853311252142e2fm, createdTime=Thu May 17 06:51:48 CST 2018, time=2018-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=315768, encodeId=6a19315e6879, content=谢谢分享学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Wed May 16 22:53:13 CST 2018, time=2018-05-16, status=1, ipAttribution=)]
    2020-08-29 朱大医生

    单位建设VTE防控体系正好用的到

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1079594, encodeId=787110e959439, content=都是干货妥妥哒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2d65095108, createdName=137*****173<手机用户>, createdTime=Mon Dec 13 16:10:51 CST 2021, time=2021-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918032, encodeId=bb8b91803217, content=最近正在学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0775454068, createdName=ms3000002065624587, createdTime=Tue Jan 19 13:09:01 CST 2021, time=2021-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=880591, encodeId=b5dd88059169, content=单位建设VTE防控体系正好用的到 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200829/fccb28c619cc4fc3b977eaa825914952/fd3510755d274e319c95dbcca5d6a542.jpg, createdBy=c8d63658569, createdName=朱大医生, createdTime=Sat Aug 29 14:05:58 CST 2020, time=2020-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=315864, encodeId=2c0c315864e7, content=好文献学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5a62240667, createdName=张新亮1853311252142e2fm, createdTime=Thu May 17 06:51:48 CST 2018, time=2018-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=315768, encodeId=6a19315e6879, content=谢谢分享学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Wed May 16 22:53:13 CST 2018, time=2018-05-16, status=1, ipAttribution=)]
    2018-05-17 张新亮1853311252142e2fm

    好文献学习了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1079594, encodeId=787110e959439, content=都是干货妥妥哒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2d65095108, createdName=137*****173<手机用户>, createdTime=Mon Dec 13 16:10:51 CST 2021, time=2021-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918032, encodeId=bb8b91803217, content=最近正在学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0775454068, createdName=ms3000002065624587, createdTime=Tue Jan 19 13:09:01 CST 2021, time=2021-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=880591, encodeId=b5dd88059169, content=单位建设VTE防控体系正好用的到 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200829/fccb28c619cc4fc3b977eaa825914952/fd3510755d274e319c95dbcca5d6a542.jpg, createdBy=c8d63658569, createdName=朱大医生, createdTime=Sat Aug 29 14:05:58 CST 2020, time=2020-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=315864, encodeId=2c0c315864e7, content=好文献学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5a62240667, createdName=张新亮1853311252142e2fm, createdTime=Thu May 17 06:51:48 CST 2018, time=2018-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=315768, encodeId=6a19315e6879, content=谢谢分享学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Wed May 16 22:53:13 CST 2018, time=2018-05-16, status=1, ipAttribution=)]
    2018-05-16 清风拂面

    谢谢分享学习

    0